Abstract:Many studies have shown a close association between Nogo-B and inflammation-related diseases. However, uncertainty does exist, regarding Nogo-B function in the pathological progression of cerebral ischemia/reperfusion (I/R) injury. Middle cerebral artery occlusion/reperfusion (MCAO/R) model was utilized in C57BL/6L mice to mimic ischemic stroke in vivo . Using oxygen-glucose deprivation and reoxygenation (ODG/R) model in microglia cells (BV-2) to establish cerebral I/R injury in vitro. Various methods, including Nogo-B siRNA transfection, mNSS and the rotarod test, TTC, HE and Nissl staining, immunofluorescence staining, immunohistochemistry, Western blot, ELISA, TUNEL and qRT-PCR were employed to probe into the effect of Nogo-B downregulation on cerebral I/R injury and the potential mechanisms. A small amount of Nogo-B expression (protein and mRNA) was observed in cortex and hippocampus before ischemia, then Nogo-B expression increased significantly on day 1, reaching the maximum on day 3, remaining stable on day 14 after I/R, and decreasing gradually after 21 days, but it still rose significantly compared with that observed preischemia. Nogo-B down-regulation could markedly reduce the neurological score and infarct volume, improve the histopathological changes and neuronal apoptosis, lower the number of CD86 + /Iba1 + cells and the levels of IL-1β, IL-6, and TNF-α, and raise the density of NeuN fluorescence, the number of CD206 + /Iba1 + cells, and the level of IL-4, IL-10 and TGF-β in brain of MCAO/R mice. Treatment with Nogo-B siRNA or TAK-242 in BV-2 cells could obviously decrease the CD86 fluorescence density and the mRNA expression of IL-1β, IL-6 and TNF-α, increase CD206 fluorescence density and the mRNA expression of IL-10 after OGD/R injury. In addition, the expression of TLR4, p-IκBα and p-p65 proteins significantly increased in the brain after MCAO/R and BV-2 cells exposed to OGD/R. Treatment with Nogo-B siRNA or TAK-242 prominently reduced the expression of TLR4, p-IκBα and p-p65. Our findings suggest that the down-regulation of Nogo-B exerts protective effect on cerebral I/R injury by modulating the microglia polarization through inhibiting TLR4/NF-κB signaling pathway. Nogo-B may be a potential therapeutic target for ischemic stroke.

Nogo‐66 Inhibits Adhesion and Migration of Microglia Via GTPase Rho Pathway in Vitro

The Nogo/Nogo Receptor (ngr) Signal is Involved in Neuroinflammation Through the Regulation of Microglial Inflammatory Activation.

Nogo Enhances the Adhesion of Olfactory Ensheathing Cells and Inhibits Their Migration

NOGO-A INHIBITS ADHESION AND MIGRATION OF MICROGLIA TO AB IN VITRO

Identification of a New Functional Domain of Nogo‐A That Promotes Inflammatory Pain and Inhibits Neurite Growth Through Binding to NgR1

Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells.

Recombinant Nogo-66 Via Soluble Expression with SUMO Fusion in Escherichia Coli Inhibits Neurite Outgrowth in Vitro

Downregulation of Nogo-B ameliorates cerebral ischemia/reperfusion injury in mice through regulating microglia polarization via TLR4/NF-kappaB pathway

Nogo receptor impairs the clearance of fibril amyloid- by microglia and accelerates Alzheimer's-like disease progression

Nogo-66 Inhibits the Dye-Coupling of Astrocytic Gap Junctions in Vitro

Microglial Nogo delays recovery following traumatic brain injury in mice

Segregation of Nogo66 Receptors into Lipid Rafts in Rat Brain and Inhibition of Nogo66 Signaling by Cholesterol Depletion.

GSK-3β activation mediates Nogo-66-induced inhibition of neurite outgrowth in N2a cells

RNA Interference Suppression of Nogo-66 Receptor Prevents Nogo-66-mediated Inhibition of Invasion and Adhesion and Simultaneously Increases Cell Apoptosis in C6 Cells

The Adhesion and Migration of Microglia to Β-Amyloid (aβ) is Decreased with Aging and Inhibited by Nogo/NgR Pathway

Integrin-linked kinase is a key signal factor involved in Nogo-66-induced inhibition of neurite outgrowth

Nogo‐66 promotes β‐amyloid protein secretion via NgR/ROCK‐dependent BACE1 activation

Lipopolysaccharide-Induced Microglial Neuroinflammation: Attenuation by FK866.

Nogo-66 receptor activation inhibits neurite outgrowth and increases β-amyloid protein secretion of cortical neurons.

Expression of Nogo receptor 1 in microglia during development and following traumatic brain injury

Nogo Receptor 3, a Paralog of Nogo-66 Receptor 1 (ngr1), May Function As a NgR1 Co-Receptor for Nogo-66